盟科药业: 上海盟科药业股份有限公司关于完成工商变更登记并换发营业执照的公告

Core Points - Shanghai Mengke Pharmaceutical Co., Ltd. has completed the registration change and obtained a new business license [1] - The company held its 14th meeting of the second board on April 22, 2025, where it approved the proposal to change the registered capital and amend the articles of association [1] - The registered capital of the company is now 655.605491 million RMB [1] Company Information - The company is classified as a joint-stock company with investments from Hong Kong, Macau, and Taiwan [1] - The legal representative of the company is Zhengyu Yuan [1] - The company is located in the China (Shanghai) Pilot Free Trade Zone [1] Business Scope - The company is engaged in the import and export of pharmaceuticals, production, wholesale, and retail of drugs [1] - It also provides technical development, services, consulting, transfer, promotion, and exchange in the pharmaceutical technology field, excluding certain specified areas [1]